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Breast ductal carcinoma in situ (DCIS) is a preinvasive form of breast cancer. It typically presents as microcalcifications
which are picked up on screening mammogram. We report an atypical case of breast DCIS presenting with recurrent
non-puerperal mastitis with a normal mammogram and perform a literature review.
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Breast ductal carcinoma in situ (DCIS) is typically
asymptomatic and presents as abnormal microcalci-
fications picked up on screening mammogram. In this
study, we report an unusual presentation of DCIS as recur-
rent non-puerperal mastitis with a normal mammogram.
Though the underlying causal relationship between breast
cancer and mastitis in this case remains unclear, this case
report highlights the importance of having a high level of
clinical suspicion in these cases of atypical presentation so
that breast cancer will not be missed.Case presentation
A 61-year-old postmenopausal woman presented with
right outer breast pain, redness and swelling of 3 days
duration. Mammogram was essentially normal at that
time. Ultrasound of her right breast revealed no masses
but increased echogenicity and skin thickening in the outer
half of her breast, likely due to inflammation. Clinical im-
pression was that of right mastitis. She was treated with 1
week of oral antibiotics and responded with resolution of
her symptoms. A follow-up ultrasound performed 1 month
later showed improvement of the inflammatory changes in
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reproduction in any medium, provided the orThe patient then remained well until she presented 8
months later with another similar episode of right mastitis
over the previously affected area. An ultrasound performed
this time again showed skin thickening in the right outer
breast with underlying inflammatory changes. No discrete
nodule or collection was seen. The patient’s symptoms
again improved with antibiotics with complete resolution
of the redness and swelling of her right breast.
However, the patient returned 6 months later present-
ing with another similar episode of right breast redness,
swelling and pain. Physical examination then revealed
right nipple retraction and signs of inflammation over
the previous area of interest. Repeat ultrasound (Figure 1)
showed marked inflammatory changes in the right breast
with skin thickening, suggestive of an inflammatory
process. Though the patient’s symptoms again responded
with antibiotics, an underlying breast malignancy, espe-
cially inflammatory breast cancer, needed to be excluded
in view of recent nipple retraction.
A skin punch biopsy and core biopsy of the inflamed
breast tissue were carried out which revealed mild superfi-
cial dermatitis on skin biopsy. Core biopsy showed DCIS
with focal chronic mastitis.
The patient underwent a right total mastectomy and
sentinel lymph node biopsy. Final histology showed a
75 mm high-grade DCIS with areas of necrosis. There was,
however, no invasive component. Some of the involved
ducts (up to 50%) showed features of cystic hypersecretory
DCIS, characterized by cystically dilated ducts containing
thyroid colloid-like eosinophilic secretions (Figure 2).td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Right breast ultrasound showing skin thickening and underlying marked inflammatory changes with increased echogenicity.
Liong et al. World Journal of Surgical Oncology 2013, 11:179 Page 2 of 4
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were clear. The estrogen and progesterone receptors status
were both negative. Her2 neu score was positive. Her post-
operative recovery was uneventful and the patient did not
require any further treatment.
Discussion
DCIS, a precursor of invasive ductal carcinoma, consists
of proliferation of cancerous cells within the lumens ofFigure 2 Hematoxylin and eosin stain, original magnification ×20. Du
hypersecretory features.the breast duct with no invasion beyond the epithelial
basement membrane [1].
Before the widespread use of screening mammogram,
DCIS often presented with a palpable breast mass or
thickening or nipple discharge or diagnosis of Paget’s
disease of the nipple [2]. Currently, however, DCIS tends
to be clinically asymptomatic and is picked up in nearly
90% of cases on mammograms as microcalcification (76%),
soft tissue densities (11%) or both (13%) [3].cts with high-grade ductal carcinoma in situ, some showing cystic
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inflammatory breast cancer or DCIS is rare. The true
incidence of these cases is unknown, though it was demon-
strated that up to 1.81% of women with non-puerperal
mastitis could eventually develop non-inflammatory
breast cancer 1 year following their mastitis [4]. In this
study, however, the site of non-inflammatory breast can-
cer is at a location distant to the infection lesion, unlike
our patient in the case report. Peters F. et al., therefore
suggests that non-puerperal mastitis may be a risk fac-
tor for breast cancer, though the underlying mechanism
is unclear [4]. Another cohort study also showed an
overall slightly increased risk of breast cancer in women
with a history of mastitis but also could not find a causal
relationship between inflammation and the development of
breast cancer [5]. It remains unclear if non-inflammatory
breast cancer or DCIS was the cause of mastitis or
vice versa.
The pathophysiology of DCIS manifesting as mastitis is
unclear. One possible explanation suggested by Damiani S
et al. is that high grade DCIS has been associated with
damage of the myoepithelial cell layer and basement mem-
brane surrounding the ductal lumen [6]. This resultant
nidus of dead ductal tissue then acted as a source for
chronic infection [7], hence resulting in the atypical mani-
festation of DCIS as mastitis.
In our case, the tumor had characteristerics of cys-
tic hypersecretory DCIS, a rare histological variant of
intraductal cancer [8]. This lesion typically shows a low-
grade behavior but can potentially become invasive and
metastasize. It does not, however, have any characteristic
clinical or mammographic features or prognostic signifi-
cance. Our atypical presentation of DCIS as mastitis may
be related to recurrent infection of the necrotic areas
within the DCIS.
An important differential diagnosis for consideration
in our case was inflammatory breast cancer which is
often misdiagnosed as mastitis. It is rare and accounts
for approximately 2.5% of all breast cancer cases [9].
Radiologically, it can sometimes present with very subtle
skin thickening without an overt mass. In fact, skin
thickening has been reported to be the most common
radiographic finding on mammogram and ultrasound
for inflammatory breast cancer [10]. Hence, the diagno-
sis of inflammatory breast cancer is often made based on
the clinical picture and pathognomonic feature of tumor
emboli blocking the dermal lymphatic channels on hist-
ology [9]. In our case, the skin punch and core biopsy
excluded inflammatory breast cancer.
Though ultrasound features of extensive skin thicken-
ing and infiltrated malignant nodes and mammographic
features of diffuse skin thickening and increased density
could help in differentiation of malignant mastitis over
the non-infectious or simple mastitis [11], non-puerperalmastitis can often have no specific mammographic or
sonographic signs [12] which are diagnostic. As a result,
a biopsy is still needed for a diagnosis and to exclude
malignant mastitis if clinically warranted.
Conclusion
DCIS can present atypically as recurrent mastitis with-
out significant suspicious imaging features. A patho-
logical investigation such as a biopsy may be necessary
to exclude breast malignancy in these rare cases, espe-
cially if there is recurrent presentation of non-puerperal
mastitis and other associated sinister clinical features.
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